World's Best Scientists 2026 revealed!
Teuvo L.J. Tammela

Teuvo L.J. Tammela

D-Index & Metrics

Medicine

D-Index
110
Citations
60204
World Ranking
5450
National Ranking
60

Overview

Teuvo L.J. Tammela is affiliated with Tampere University in Finland. Their research activity focuses extensively on areas involving medicine and biochemistry, genetics, and molecular biology, as evidenced by the large number of publications in these fields.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields covered in their work are:

  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Oncology
  • Radiology, Nuclear Medicine and Imaging
  • Surgery

The research topics frequently addressed by Teuvo L.J. Tammela encompass:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Radiopharmaceutical Chemistry and Applications
  • Global Cancer Incidence and Screening
  • Cancer Treatment and Pharmacology
  • Lipoproteins and Cardiovascular Health

They have notable contributions in several publication venues, with frequent appearances in:

  • Cancer Research
  • European Urology Open Science
  • Journal of Clinical Oncology
  • PLoS ONE
  • Scandinavian Journal of Urology

Among the prominent papers associated with their work are the following:

  • "Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction," 2021, Nature Genetics
  • "Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide," 2020, New England Journal of Medicine
  • "Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse," 2021, Nature Communications
  • "Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study," 2021, European Urology Oncology
  • "Prostate cancer risk prediction using a polygenic risk score," 2020, Scientific Reports

Frequent collaborators in research include:

  • Anssi Auvinen
  • Teemu J. Murtola
  • Kimmo Taari
  • Kirsi Talala
  • Karim Fizazi

Best Publications

  • Screening and Prostate-Cancer Mortality in a Randomized European Study

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

    Tapio Visakorpi;Eija Hyytinen;Pasi Koivisto;Minna Tanner

  • Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela

  • Prostate-Cancer Mortality at 11 Years of Follow-up

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • MicroRNA Expression Profiling in Prostate Cancer

    Kati P. Porkka;Minja J. Pfeiffer;Kati K. Waltering;Robert L. Vessella

  • Denosumab in men receiving androgen-deprivation therapy for prostate cancer

    Matthew R. Smith;Blair Egerdie;Narciso Hernández Toriz;Robert Feldman

  • Effect of dutasteride on the risk of prostate cancer.

    Gerald L. Andriole;David G. Bostwick;Otis W. Brawley;Leonard G. Gomella

  • Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer

    Marika J. Linja;Kimmo J. Savinainen;Outi R. Saramäki;Teuvo L. J. Tammela

  • Overdiagnosis and Overtreatment of Prostate Cancer

    Stacy Loeb;Marc A. Bjurlin;Joseph Nicholson;Teuvo L. Tammela

  • Androgen Receptor Gene Amplification: A Possible Molecular Mechanism for Androgen Deprivation Therapy Failure in Prostate Cancer

    Pasi Koivisto;Juha Kononen;Christian Palmberg;Teuvo Tammela

  • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.

    Matthew R Smith;Fred Saad;Robert Coleman;Neal Shore

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

    Karim Fizazi;Neal Shore;Teuvo L. Tammela;Albertas Ulys

  • Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

    Rosalind A. Eeles;Ali Amin Al Olama;Sara Benlloch;Edward J. Saunders

  • Evidence for a prostate cancer susceptibility locus on the X chromosome.

    Jianfeng Xu;Deborah Meyers;Diha Freije;Sarah Isaacs

  • Genetic Changes in Primary and Recurrent Prostate Cancer by Comparative Genomic Hybridization

    Tapio Visakorpi;Anne H. Kallioniemi;Ann-Christine Syvänen;Eija R. Hyytinen

  • Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer

    Seppo Pyrhönen;Eeva Salminen;Mirja Ruutu;Timo Lehtonen

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Jonas Hugosson;Monique J. Roobol;Marianne Månsson;Teuvo L.J. Tammela

  • A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

    Ali Amin Al Olama;Zsofia Kote-Jarai;Sonja I. Berndt;David V. Conti

  • Darolutamide in nonmetastatic, castration-resistant prostate cancer

    Fizazi K;Shore N;Tammela Tl;Ulys A

Frequent Co-Authors

Anssi Auvinen
Anssi Auvinen Tampere University
Johanna Schleutker
Johanna Schleutker Turku University Hospital
Matti Hakama
Matti Hakama Finnish Cancer Registry
Lisa A. Cannon-Albright
Lisa A. Cannon-Albright University of Utah
Graham G. Giles
Graham G. Giles University of Melbourne
Ulf-Håkan Stenman
Ulf-Håkan Stenman University of Helsinki
Tapio Visakorpi
Tapio Visakorpi Tampere University
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
Fredrik Wiklund
Fredrik Wiklund Karolinska Institute
Henrik Grönberg
Henrik Grönberg Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying Medicine in the USA but seeking flexible, affordable alternatives, a variety of online healthcare degrees and career paths are available. Many students begin their journey with affordable nursing programs online, providing entry points into the nursing profession with reduced tuition costs and flexible schedules.

For those who already hold an RN license, advancing your education with one of the affordable rn to bsn programs can open up leadership, administrative, or specialized clinical roles without having to pause your current job.

Professionals seeking the highest level of nursing education can pursue online phd programs nursing, which are ideal for careers in research, teaching, or advanced clinical practice.

Even those without a nursing background can transition into high-demand healthcare fields via online msn programs for non nurses. These direct-entry master’s paths provide a streamlined way for non-nurses to gain advanced skills and credentials, helping bridge the healthcare workforce gap.

Best Scientists Citing Teuvo L.J. Tammela

Trending Scientists

Recently Published Articles